Important Announcement of Listed Companies: Zhong Aluminum International plans to sell 52.6%of Miyu Company for 1.281 billion yuan
Author:Securities daily Time:2022.09.26
Zhong Aluminum International: It is intended to sell 52.6%of Miyu Company for the sale of 52.6%of the equity of Miyu Company: Shengshi Trade intends to issue some of the acquisition offers to the investment offer investment ship: sign 2+2 LNG ships to make a intention to make a letter of intent to Long Shenrongfa: intends to use it to do so326 million yuan acquired 70%equity of Pu'an Pharmaceutical Equity Dongtian Micro: The company's secretary was specified in the surveillance and residence
China Aluminum International: It is intended to sell 52.6%of Miyu Company's 52.6%equity of China Aluminum International (601068) for the sale of 1.281 billion yuan. Yu Company 53.8%of the equity. This transaction is the first transfer, that is, the transfer of 52.6%of Miyu Company, the transaction consideration is 1.281 billion yuan. The target company is the project company of the G8012 Maitreya to Chuxiong Highway Maitreya to Yuxi section project PPP project. The project is still in the construction investment period. After the transaction is completed, the company's main business has not changed, and the company will gradually withdraw from the aforementioned PPP project. China Merchants Ship: Sign 2+2 LNG Ship Booking Winning Book Intentional Book China Merchants Ship (601872) Announcement, the company exercised the right to build a choice of ship construction on September 24, and set up 2 ships to Dalian Shipbuilding Group Co., Ltd. and China Shipbuilding Industry Trade Co., Ltd. 175,000 cubic meters of large liquefied natural gas (LNG) transport ships and signed the "Ship Booking Agreement". On the same day, the company signed a 2+2 LNG ship's "Book of Board of Construction Cooperation in the Second Phase of LNG Ship" with a heavy worker in large ships. Two ships of 175,000 cubic meters of LNG transport ships with a total price of 400 million US dollars; the delivery period is in the second half of 2026. Yongtai Energy: The Energy Storage Technology Company Detai Storage Energy completed the establishment of Yongtai Energy (600157) Announcement. 51%, Hede Co., Ltd. invested 490 million yuan and held 49%. China Heavy Industry: The Subsidiary Shipbuilding Group signed the relocation construction and upgrading project related cooperation agreement China Heavy Industry (601989) announcement. Two cooperation agreements signed the "Big Ship Group Relocation Construction and Upgrade" project on September 24, including the "Strategic Cooperation Agreement of the" Relocation and Construction of the Big Ship Group "and the" Removal Construction and Upgrade of the Big Ship Group-Taiping Bay High-end Ship Development and Construction Base Project Project Cooperation Agreement " Huitong Energy: Shengshi Trade intends to issue some of the acquisition offers (600605) announcement to all shareholders. The number of shares is 10.3141 million shares, accounting for 5.00%of the total share capital of Huitong Energy, and the contract price is 19.28 yuan. After the acquisition of the offer was completed, the Holy Stone Trade and its consistent actions of humanities stone trade held up to 72.1417 million shares of Huitong Energy, accounting for about 34.97%of the company's total share capital. Nanqiao Food: One of the actual controller died of the death of Nanqiao Food (605339). Chen Feipeng did not work in the company during his lifetime, and his death would not have a significant impact on the company's production and operation. Important Announcement in Shenzhen City: It is intended to acquire 70%of Pu'an Pharmaceutical Long Shen Rongfa (300534) for the acquisition of 326 million yuan. 70%of Pu'an Pharmaceutical's equity, with a total consideration of 326 million yuan. Dongtian Micro: The company's director was specified to be monitored to live in Dongtian Wei (301183) announced. Zhang Xiaobo, secretary and chief financial officer of the company's board of directors, was performed by the Public Security Organs of Taizhou City in Zhejiang Province for suspected crime. According to the company's preliminary understanding, Zhang Xiaobo involved in the above matters is his personal case, which has nothing to do with the company and the company's enterprises. At present, the company's operating situation is normal. Coron Pharmaceutical: Cross of Lerme Dingli Eye Dipping Eye Dipping Eye Drug Registration Approval Corlen Pharmaceutical (002422) Announcement, the chemical "Bromani Dingbuka in Moni Dingbin, Jiangxi Coren Pharmaceutical Co., Ltd., the subsidiary of the subsidiary "Eye Dripping" has been approved by the State Drug Administration's drug registration recently. Corporate bromeni Dingbu is approved for the first imitation in China. After listing, it will provide domestic glaucoma patients with dual effects of lowering eye pressure and optic nerve protection. Shuangcheng Pharmaceutical: Signing the injection of paclitaxel (white protein -binding) permissions and supply agreements Shuangcheng Pharmaceutical (002693) announcement, the company signed the License and Supply Agreement with Meitheal and HKF. The agreement stipulates that the company's exclusive permission to the development and production of paclitaxel (ballasty) (100mg/bottle) in the United States is awarded Meitheal and HKF in the United States. Meitheal is responsible for injecting the market planning and sales of paclitaxel (ballasty) in the United States. After the product is listed, Meitheal should pay the profit sharing of products sales in the United States. HKF needs to pay a certain one -time milestone to the company, with a total amount of $ 6 million. Guangshengtang: New Guan Oral Small Molecular Innovation Pharmaceutical GST-HG171 was approved by the clinical trial Guangshengtang (300436) announcement. Oral Small Permanent Virus 3CL protease inhibitors, such as innovative drug GST-HG171, "Approval Notice of Pharmaceutical Clinical Test", have achieved key milestones in the innovative research and development of new crown drugs.
The GST-HG171 has a broad-spectrum anti-new coronal virus activity, which has efficient virus inhibitory activity for the primitive strains of the new crown virus, Omikon BA.4, BA.5, and Beta, Delta mutant strains.Hengguang Co., Ltd.: It is planned to invest in the construction of the Laos chlorine project Hengguang (301118) announced at a less than 150 million yuan.Construction projects are expected to exceed 150 million yuan.A set of 30,000 tons of chloroine production devices in the first phase, and then promoted the construction of the downstream industrial chain of the second phase of salt chemical products in a timely manner according to the situation.Anti -holding Taoism (002852) Announcement, Zhang Jun, a director and senior managers holding 0.6764%of the shares, plans to reduce the shares of the company within six months after the announcement of the announcement.The company's total share capital ratio was 0.1279%).I know you are "watching"
- END -
Shangtang-Way in the first half of 2022, net loss of 3.21 billion yuan, R & D expenditure 2.04 billion yuan
On August 25, 2022, Shangtang-W (00020.HK), a listed company of Hong Kong stocks, ...
Who is "dazzling" by the digital economy?Weihai activity ranks in the top three in the province
A few days ago, Volkswagen Daily Data News Studio combined with an illusion analys...